Association of remnant cholesterol with CVD incidence: a general population cohort study in Southwest China.

Background: Emerging evidence has indicated that remnant cholesterol (RC) could predict cardiovascular disease (CVD) incidence. Nevertheless, the relationship between RC and CVD risk, especially within the general Chinese population, remains scarce. Objective: The present research aimed to assess whether RC concentrations and CVD outcomes in general Chinese adults are related. Methods: The Cox proportional hazard model was established to explore the relationship between RC and the outcomes of CVD and CVD subgroups. A restricted cubic spline (RCS) was utilized to investigate the dose-response connection between RC and the risk of CVD outcomes, and the ROC curve was used to calculate the corresponding cutoff values. Moreover, stratified analysis was conducted to investigate the potential effect modification in the association between RC and CVD outcomes. Results: Significant positive associations were found between elevated categorical RC and increased risk of CVD (HR Q4, 1.80; 95% CI 1.15-2.79; P-value = 0.008), atherosclerotic cardiovascular disease (HR Q4, 2.00; 95% CI 1.22-3.27; P-value = 0.007), stroke (HR Q4, 1.66; 95% CI 1.02-2.69; P-value = 0.040), and ischemic stroke (HR Q4, 1.87, 95% CI 1.08-3.25; P-value = 0.034), respectively. Our study suggested that the incidence of CVD outcomes increased when RC levels were above 0.75 mmol/L. Importantly, the CVD risks related to RC were more likely to be those found in subjects aged above 60 years, women, subjects with BMI <24 kg/m2, and subjects with hypertension and unhealthy diet patterns. Conclusions: Aberrant high level of RC is associated with elevated CVD risk, independent of low-density lipoprotein cholesterol (LDL-C). Our data reveal urgent primary prevention for subjects with high RC levels to a low incidence of CVD, especially for the elderly, women, and those with hypertension and unhealthy diet patterns.

Management guideline for the off-label use of medicine in China (2021).

BACKGROUND: Off-label drug use embodies a thorough clinical diagnosis and evaluation of treatment needs and should not be confused with unreasonable drug use, but it also faces potential risks with drug safety and legal issues. RESEARCH DESIGN AND METHODS: We first established a guideline working group. Following the guideline development process recommended by the World Health Organization Handbook and the Chinese Medical Association, the key questions were determined through literature searches of PubMed, CNKI (Chinese National Knowledge Infrastructure) and other databases. Both the evidence and the clinicians' diagnosis and treatment workload were considered to formulate the initial recommendations. Finally, two rounds of Delphi surveys and one expert seminar were organized to determine the final recommendations of this guideline. Meanwhile, we graded the recommendations based on the body of evidence. RESULTS: We determined nine questions and proposed a total of 23 recommendations regarding the definition of off-label use of drugs, applicable circumstances, classification of evidence, informed consent, legal basis, adverse drug reaction monitoring and evaluation, management procedure, responsibilities and obligations of different stakeholders, medical insurance reimbursement, and the national approval system. CONCLUSIONS: This guideline standardized clinical off-label drug use and provided suggestions and references for the management of off-label drug use.

Dropped head syndrome: a rare adverse drug reaction identified in the FDA adverse event reporting system and review of case reports in the literature.

BACKGROUND: Dropped head syndrome (DHS) is a relatively rare disease, and its potential relationship with drug exposure has been postulated but is poorly understood. RESEARCH DESIGN AND METHODS: This retrospective study evaluated the adverse event reports of DHS in the FDA adverse event reporting system （FAERS) between 1 January 2004, to 31 March 2021. Empirical Bayes Geometric Means (EBGM) and the lower 95% one-sided CI of EBGM were calculated to identify disproportionate reporting of DHS associated with drugs. In addition, published case reports were identified in the PubMed, Embase and Cochrane Library up to 5 August 2021. RESULTS: There were 193 reports of DHS in the FAERS, in which nervous system agents were most frequently reported, followed by antineoplastic and immunomodulating agents. Pramipexole, ropinirole, levodopa, pregabalin, rotigotine, cisplatin, imatinib and botulinum toxin showed disproportionality signal based each on more than 5 cases. Ten published DHS case reports were identified in the literature. CONCLUSION: Our study provides a more explicit profile on the occurrences and characteristics of DHS associated with drugs by analyzing the FAERS data and indicates that exposure of certain drug showed disproportionality signal with the increased DHS risk, which suggests the importance of further clinical and observational investigations.

Highly Active and Stable Fe-N-C Oxygen Reduction Electrocatalysts Derived from Electrospinning and In Situ Pyrolysis.

High-performance electrocatalysts for the oxygen reduction reaction (ORR) are essential in electrochemical energy storage and conversion technologies. Fe-N-C electrocatalysts have been developed as one of the most promising alternatives to precious metal materials. Current M-N-C electrocatalysts usually are derived from high-temperature thermal treatment of a nitrogen-containing polymer or metal-organic frameworks (MOFs). Here, we developed Fe-N-C mesoporous nanofibers with low-cost urea and FeCl3 as the nitride and iron source; the electrocatalysts with abundant Fe-Nx active sites and large surface area were synthesized via electrospinning, in situ pyrolysis, and acid treatment process. The use of sealing conditions in the calcination process can effectively improve the nitrogen species content in the catalyst, which is important for improving performance. The as-prepared electrocatalyst material manifests well electrocatalytic performance for ORR in alkaline electrolyte (onset potential of 0.93 V and half-wave potential of 0.82 V); meanwhile, the electrocatalyst expresses good stability and methanol tolerance. This work may provide new thought for developing high-performance ORR electrocatalysts.

Synthesis of Water-Soluble Antimony Sulfide Quantum Dots and Their Photoelectric Properties.

Antimony sulfide (Sb2S3) has been applied in photoelectric devices for a long time. However, there was lack of information about Sb2S3 quantum dots (QDs) because of the synthesis difficulties. To fill this vacancy, water-soluble Sb2S3 QDs were prepared by hot injection using hexadecyltrimethylammonium bromide (CTAB) and sodium dodecyl sulfate (SDS) mixture as anionic-cationic surfactant, alkanol amide (DEA) as stabilizer, and ethylenediaminetetraacetic acid (EDTA) as dispersant. Photoelectric properties including absorbing and emission were characterized by UV-Vis-IR spectrophotometer and photoluminescence (PL) spectroscopic technique. An intensive PL emission at 880 nm was found, indicating Sb2S3 QDs have good prospects in near-infrared LED and near-infrared laser application. Sb2S3 QD thin films were prepared by self-assembly growth and then annealed in argon or selenium vapor. Their band gaps (E g s) were calculated according to transmittance spectra. The E g of Sb2S3 QD thin film has been found to be tunable from 1.82 to 1.09 eV via annealing or selenylation, demonstrating the good prospects in photovoltaic application.

Preparation and Characterization of Mo Doped in BiVO4 with Enhanced Photocatalytic Properties.

Molybdenum (Mo) doped BiVO4 was fabricated via a simple electrospun method. Morphology, structure, chemical states and optical properties of the obtained catalysts were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), UV-vis diffuse reflectance spectroscopy (DRS), N2 adsorption-desorption isotherms (BET) and photoluminescence spectrum (PL), respectively. The photocatalytic properties indicate that doping Mo into BiVO4 can enhance the photocatalytic activity and dark adsorption ability. The photocatalytic test suggests that the 1% Mo-BiVO4 shows the best photocatalytic activity, which is about three times higher than pure BiVO4. Meanwhile, 3% Mo-BiVO4 shows stronger dark adsorption than pure BiVO4 and 1% Mo-BiVO4. The enhancement in photocatalytic property should be ascribed to that BiVO4 with small amount of Mo doping could efficiently separate the photogenerated carries and improve the electronic conductivity. The high concentration doping would lead the crystal structure transformation from monoclinic to tetragonal phase, as well as the formation of MoO3 nanoparticles on the BiVO4 surface, which could also act as recombination centers to decrease the photocatalytic activity.

Enhanced Photocatalytic Activity of the Carbon Quantum Dot-Modified BiOI Microsphere.

Novel carbon quantum dot (CQD)-modified BiOI photocatalysts were prepared via a facile hydrothermal process. The CQD-modified BiOI materials were characterized by multiple techniques. The CQD with an average size around several nanometers was distributed on the surface of BiOI microsphere. Its photocatalytic activity was investigated sufficiently by the photodegradation of methylene orange (MO). The results showed that the CQD/BiOI 1.5 wt.% sample exhibited the optimum photocatalytic activity, which was 2.5 times that of the pure BiOI. This improvement was attributed to the crucial role of CQDs, which could be acted as a photocenter for absorbing solar light, charge separation center for suppressing charge recombination.